Vulvovaginal trichomoniasis: epidemiology, clinical and parasitological characteristics

##plugins.themes.academic_pro.article.main##

Dorsaf Aloui
Sonia Trabelsi
Meriem Bouchekoua
Samira Khaled

Abstract

Background: Trichomonas vaginalis infection is the most prevalent nonviral sexual transmitted infection. The World Health Organization estimates that its prevalence is 170 million cases worldwide eachyear. In women, he represents the third cause of vaginitis.
Aim : to determine the prevalence, to evaluate predisposing factors and to study the clinical and parasitological characteristics of vulvovaginal trichomoniasis in a Tunisian population during a period of 18 months.
Methods : This is a transversal study concerning 924 women. We administered a questionnaire to obtain information about the possible risk factors of vulvovaginal trichomoniasis. Vaginal swabs were collected with the help of sterile transportable cotton swabs, followed by microscopic examination. Data were statistically analyzed.
Results : Trichomonas vaginalis infection was diagnosed in 3,5% of cases. The study various potential risk factors showed that trichomoniasis was significatively associated with multiple partners, long-term corticotherapy. However, the pregnancy was a protector factor.
Conclusion: The research for factors allows not only to explain the appearance of this infection but also, and especially, to establish a disease prevention to avoid their second offense or, at best their arisen in women at risk.

Keywords:

Trichomonas vaginalis ; vulvovaginitis; epidemiology; diagnosis; Tunisia.

##plugins.themes.academic_pro.article.details##

References

  1. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: Overview and estimates. Geneva: World Health Organization 2005.
  2. Sobel JD. Vulvovaginitis, when Candida becomes a problem. Sex Transm Dis 1998;16:763-8.
  3. Sobel JD. Vulvovaginal candidosis. Lancet 2007;369:1961-71.
  4. Fortenberry JD, Brizendine EJ, Katz BP, Wools KK, Blythe MJ, Orr DP. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis. Sex Transm Dis 1999;26:26-32.
  5. Shuter J, Bell D, Graham D, Holbrook KA, Bellin EY. Rates of and risk factors for trichomoniasis among pregnant inmates in New York City. Sex Transm Dis 1998;25:303-7.
  6. Sen AC, Miller WC, Hobbs MM et al. Trichomonas vaginalis Infection in Male Sexual Partners: Implications for Diagnosis, Treatment, and Prevention. Clin Infect Dis 2007;44:13-22.
  7. Miller WC, Swygard H, Hobbs MM et al. The prevalence of Trichomoniasis in young adults in the United States. Sex Transm Dis 2005;32:593-8.
  8. Sutton M, Sternberg M, Koumans EH, Mc Quillan G, Berman S, Markowitz L. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis 2007;45:1319-26.
  9. Spinillo A, Bernuzzi AM, Cevini C, Gulminetti R, Luzi S, De Santolo A. The relationship of bacterial vaginosis, Candida and Trichomonas infection to symptomatic vaginitis in postmenopausal women attending a vaginitis clinic. Maturitas 1997;27:253-60.
  10. Madhivanan P, Bartman MT, Pasutti L et al. Prevalence of Trichomonas vaginalis infection among young reproductive age women in India: implications for treatment and prevention. Sex Health 2009;6:339-44.
  11. Faye-Kette YH, Kouassi AA, Sylla-Koko DF et al. Prevalence of 4 agents of sexually transmitted diseases in leukorrhea in Abidjan (Ivory Coast). Bull Soc Pathol Exot 1993;86:245-7.
  12. Sullam SA, Mahfouz AA, Dabbous NI, El-Barrawy M, El-Said MM. Reproductive tract infections among married women in Upper Egypt. East Mediterr Health J 2001;7:139-46.
  13. Benchellal M, Guelzim K, Lemkhente Z et al. La candidose vulvovaginale à l'hôpital militaire d'instruction Mohammed V (Maroc). J Mycol Med 2011;21:106-12.
  14. Belhadj S, Idir L, Mahaman BA, Kallel K, Chaker E. Les vaginites parasitaires et mycosiques: prévalence et agents étiologiques bilan de 3 ans à l'hôpital la Rabta de Tunis (1994-96). Essaydali 1997;63:17-8.
  15. Zribi M, Ben Mansour K, Abid F, Masmoudi A, Fendri C. Syndromic approach to sexually transmitted infections in Tunisian women: bacteriological validation. Int J STD AIDS 2008;19:112-4.
  16. Anane S, Kaouech E, Zouari B, Belhadj S, Kallel K, Chaker E. Les candidoses vulvovaginales : facteurs de risque et particularités cliniques et mycologiques. J Mycol Med 2010;20:36-41.
  17. Bowden FJ, Paterson BA, Mein J. Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and human papillomavirus infection in indigenous women in northern Australia. Sex Transm Inf 1999;75:431-4.
  18. Sena AC, Miller WC, Hobbs MM et al. Trichomonas vaginalis Infection in male sexual partners: Implications for diagnosis, treatment, and prevention. Clin Infect Dis 2007;44:13-22.
  19. Association française des enseignants de parasitologie et mycologie médicales. Candidoses. Dans: Association française des enseignants de parasitologie et mycologie médicales, eds. Parasitoses et mycoses des régions tempérées et tropicales. Paris: Masson 2007:241-50.
  20. Brasseur P. Agent de la trichomonose urogénitale. Encycl Med Chir- Biologie clinique 2003;90-40-0015.
  21. Duran N, Çulha G, Hakverdi AU, Güngören A. The investigation of the association between the frequency of Trichomonas vaginalis and using intrauterine contraceptive device. Trakya Univ Tip Fak Derg 2009;26:197-202.
  22. Demirezen S. Trichomonas vaginalis in vaginal smears of women using intrauterine contraceptive device. Cent Eur J Public Health 2001;9:176-8.
  23. Nasir JA, Najma J, Tahir F, Asghar N, Iqbal J. Trichomonas vaginalis in vaginal smears of women using intrauterine contraceptive device. Pak J Med Res 2005;44:114-6.
  24. Garber GE, Lemchuck-Favel LT, Bowie WR. Isolation of a cell-detaching factor of Trichomonas vaginalis. J Clin Microbiol 1989;27:1548-53.
  25. Datry A. Trichomonose génitale. Dans: Nozais JP, Datry A, Danis M, eds. Traité de parasitologie médicale. Paris: Editions Pradel, 1996:307-8.
  26. Soper D. Trichomoniasis: Under control or undercontrolled? Am J Obstet Gynecol 2004;190:281-90.